Article
MAP3K1 rs889312 polymorphism and cancer prognosis: A systematic review and meta-analysis.
Cancer reports (Hoboken, N.J.) - 1 Jan 2023
Aziz Md Abdul, Islam Mohammad Safiqul
Abstract excerpt
BACKGROUND: Accumulating studies have evaluated the association between MAP3K1 polymorphisms and cancer prognosis. However, the results of these studies are conflicting. Given the potential impact of MAP3K1 rs889312 SNP on the prognosis of various cancers, this meta-analysis was performed to obtain solid and credible evidence. METHODS AND MATERIALS: This study was performed according to the PRISMA 2020 statement....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
